Market cap
₹131 Cr
Revenue (TTM)
₹24 Cr
P/E Ratio
--
P/B Ratio
11.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 1.48 | -22.65 | -1.86 | 20.65 | 6.36 |
| EBIT | -1,613.64 | -163.11 | -206.09 | -190.24 | -201.49 |
| Net Profit | -2,950.00 | -163.20 | -201.29 | -191.52 | -204.01 |
| EPS | -2,951.49 | -163.19 | -201.29 | -191.51 | -203.81 |
| Book Value | -- | -- | 0.12 | -1.38 | 8.03 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| -3.90 | 2.46 | -14.61 | -0.30 | 9.23 |
| Net Margin
| -3.38 | 2.38 | -14.04 | 0.20 | 9.26 |
| Return on equity
| -1.46 | 7.44 | -29.63 | 0.42 | 18.54 |
| Return on Capital
| 1.47 | 9.69 | -- | 3.26 | 19.64 |
| Return on Assets
| -1.17 | 5.16 | -17.50 | 0.28 | 12.86 |
| Debt to Equity (x)
| -- | -- | 0.13 | 0.11 | 0.10 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
3.26
|
19.64
|
-18.49
|
2.40
|
|
Peer Median
|
--
|
3.26
|
-2.22
|
4.55
|
--
|
ROE
-29.63
Lower than Peers by 30.59
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-29.63
|
0.42
|
18.54
|
-23.34
|
-0.69
|
|
Peer Median
|
0.96
|
0.42
|
-3.56
|
2.06
|
--
|
ROA
-17.50
Lower than Peers by 18.34
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-17.50
|
0.28
|
12.86
|
-16.67
|
-0.50
|
|
Peer Median
|
0.84
|
0.28
|
-2.73
|
1.49
|
--
|
EBIT Margin
-14.61
Lower than Peers by 20.96
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-14.61
|
-0.30
|
9.23
|
-20.64
|
0.05
|
|
Peer Median
|
6.34
|
0.50
|
8.20
|
8.08
|
--
|
Net Margin
-14.04
Lower than Peers by 19.95
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-14.04
|
0.20
|
9.26
|
-19.61
|
-0.60
|
|
Peer Median
|
5.91
|
0.20
|
-0.01
|
3.55
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
0.00
|
6.36
|
16.21
|
-8.58
|
10.35
|
|
Peer Median
|
0.00
|
--
|
0.00
|
0.00
|
--
|
Revenue Growth
-1.86
Lower than Peers by 12.82
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-1.86
|
13.56
|
66.60
|
-8.66
|
-26.02
|
|
Peer Median
|
10.97
|
14.08
|
9.33
|
2.48
|
--
|
EBIT Growth
-206.09
Lower than Peers by 196.76
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-206.09
|
-103.70
|
174.52
|
-35,963.16
|
-99.84
|
|
Peer Median
|
-9.34
|
16.96
|
92.72
|
40.29
|
--
|
Net Profit Growth
-201.29
Lower than Peers by 157.87
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-201.29
|
-97.52
|
177.56
|
-2,912.63
|
-101.99
|
|
Peer Median
|
-43.42
|
-74.09
|
71.34
|
17.91
|
--
|
EPS Growth
-201.29
Lower than Peers by 174.57
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-201.29
|
-97.53
|
177.56
|
-2,911.72
|
-101.99
|
|
Peer Median
|
-26.72
|
-74.09
|
71.34
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
0.12
|
20.44
|
-20.45
|
-0.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.13
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
0.13
|
0.11
|
0.10
|
0.11
|
0.08
|
|
Peer Median
|
--
|
0.12
|
0.14
|
0.11
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.43
Lower than Peers by 0.12
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
1.43
|
1.47
|
2.26
|
2.10
|
3.70
|
|
Peer Median
|
1.55
|
1.47
|
1.91
|
2.45
|
--
|
Quick Ratio
1.19
Higher than Peers by 0.02
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
1.19
|
1.25
|
2.05
|
1.89
|
3.44
|
|
Peer Median
|
1.17
|
1.12
|
1.42
|
1.81
|
--
|
Interest Coverage
-7.55
Lower than Peers by 23.83
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-7.55
|
1.13
|
6.97
|
-6.27
|
0.79
|
|
Peer Median
|
16.28
|
1.13
|
-1.38
|
4.03
|
--
|
Operating Efficiency
Debtors to sales
11.03
Higher than Peers by 0.48
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
11.03
|
6.94
|
10.69
|
16.98
|
16.17
|
|
Peer Median
|
10.55
|
11.03
|
19.78
|
16.98
|
--
|
Asset Turnover
1.22
Higher than Peers by 0.51
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
1.22
|
1.39
|
1.37
|
0.82
|
0.82
|
|
Peer Median
|
0.71
|
0.75
|
1.11
|
0.78
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
29.85
|
38.11
|
63.31
|
86.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
8.83
|
7.95
|
11.69
|
10.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
75.83
|
72.32
|
74.56
|
69.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
-37.16
|
-26.26
|
0.44
|
26.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-37.91
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-37.91
|
1,121.49
|
42.33
|
--
|
--
|
|
Peer Median
|
--
|
1,419.70
|
162.58
|
47.34
|
--
|
Price / Book Value
11.84
Higher than Peers by 8.34
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
11.84
|
4.70
|
7.18
|
3.15
|
2.25
|
|
Peer Median
|
3.51
|
3.15
|
2.70
|
1.79
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-93.75
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
-93.75
|
28.88
|
22.18
|
-41.27
|
14.25
|
|
Peer Median
|
--
|
-3.07
|
-19.96
|
20.34
|
--
|
Market Cap
131
No difference
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Aspira Pathlab
|
131
|
57
|
88
|
32
|
29
|
|
Peer Median
|
131
|
131
|
55
|
32
|
--
|